DC Health reports decline in teen births and infant mortality rates

Federal Issues PhRMA COO: 340B misuse is 'driving up taxpayer costs with no proof that patients benefit' Nov 19, 2025

State Issues South Dakota’s Bright Start program linked to improved child health outcomes Nov 17, 2025

State Issues Mayor Bowser opens new animal shelter and starts construction on fleet campus Nov 8, 2025

State Issues Georgia Board of Pharmacy offices closed for in-person visits Nov. 10-11 Nov 7, 2025

Regulatory Patients Come First executive director: Misleading lawsuit ads leave 'patients confused and unprotected’ Nov 6, 2025

Federal Issues Pacific Research Institute CEO on 340B program: 'Even the most well-intentioned government initiatives can easily fall victim to corruption' Nov 5, 2025

People

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program Sep 22, 2025

• CDC releases COVID-19 guidance for those with health conditions
• Leonard named new president of the Association for Accessible Medicines
• Best in health care showcased in 2020 We Work for Health Champion Awards
• Grein: Those suffering from COVID-19 receiving experimental treatments

Innovation

Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

• Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
• PTCB: Pharmacy Technician Certification Board (PTCB) Rolls Out Advanced Certification for Experienced Pharmacy Technicians Who Have Comprehensive Knowledge and Skills
• AZD1222 vaccine meets base requirements in efficacy for preventing, treating COVID-19
• endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows

Regulatory

Patients Come First executive director: Misleading lawsuit ads leave 'patients confused and unprotected’ Nov 6, 2025

• ICER report highlights patent review as key to lowering GLP-1 drug costs
• BPI Labs joins Empower Pharmacy in challenging Eli Lilly’s tirzepatide patent over GLP-1 exclusivity
• AG Paxton on Texas suing Eli Lilly: They 'put corporate greed over people’s health'
• CEO of Empower Pharmacy: 'The smear campaign against compounded GLP-1s was never about safety'

Industry

Trader on Eli Lilly lawsuit: 'There is decades of legal precedent allowing the compounding of medications under the 503A exemption' Jun 27, 2025

• Empower Pharmacy founder: 'The most expensive part of your medication isn’t the drug. It’s the middleman'
• Empower Pharmacy CEO on pharmaceutical lobbying pressure: 'A resurgence of compounding is coming'
• Empower Pharmacy challenges Eli Lilly tirzepatide patent before U.S. Patent Trial and Appeal Board
• Monty's Home Medical highlights benefits of tailored compounded medications

Federal Issues

PhRMA Senior Director Jenkins on 340B misuse: 'Tax-exempt hospitals exploit the 340B program as a profit center' Nov 25, 2025

• Paragon Health Institute Director on 340B: 'The heart of the problem is the program’s buy low, sell high mechanism'
• PhRMA COO: 340B misuse is 'driving up taxpayer costs with no proof that patients benefit'
• Pacific Research Institute CEO on 340B program: 'Even the most well-intentioned government initiatives can easily fall victim to corruption'
• PhRMA Public Affairs director on 340B program reform: 'It’s time for Congress to fix 340B'

State Issues

DC Health reports decline in teen births and infant mortality rates Nov 26, 2025

• Mayor Bowser opens new Fort Totten–Takoma segment of Metropolitan Branch Trail
• NCPA, PTCB and PCCA introduce national compounding technician training program
• South Dakota recognizes National Rural Health Day; Jones County Ambulance named Community Star
• NCPA, PTCB and PCCA introduce national compounding training program for pharmacy technicians